AVITA Medical Inc’s recent filing unveils that its CFO O’Toole David D acquired Company’s shares for reported $8900.0 on May 30 ’24. In the deal valued at $8.90 per share,1,000 shares were bought. As a result of this transaction, O’Toole David D now holds 19,734 shares worth roughly $0.16 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, O’Toole David D bought 1,250 shares, generating $21,738 in total proceeds. Upon buying the shares at $17.39, the CFO now owns 18,734 shares.
Before that, CORBETT JAMES sold 1,445 shares. AVITA Medical Inc shares valued at $19,204 were divested by the CEO at a price of $13.29 per share. As a result of the transaction, CORBETT JAMES now holds 11,580 shares, worth roughly $91250.4.
BTIG Research downgraded its AVITA Medical Inc [RCEL] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in late June with a ‘”an Overweight”‘ rating. Piper Sandler began covering RCEL with “an Overweight” recommendation on March 02, 2021. BofA Securities started covering the stock on August 27, 2020. It rated RCEL as “a Buy”.
Price Performance Review of RCEL
On Tuesday, AVITA Medical Inc [NASDAQ:RCEL] saw its stock jump 2.07% to $7.88. Over the last five days, the stock has lost -0.76%. AVITA Medical Inc shares have fallen nearly -42.57% since the year began. Nevertheless, the stocks have fallen -53.67% over the past one year. While a 52-week high of $21.70 was reached on 02/27/24, a 52-week low of $7.51 was recorded on 05/14/24. SMA at 50 days reached $8.55, while 200 days put it at $12.42. A total of 0.25 million shares were traded, compared to the trading of 0.32 million shares in the previous session.
Levels Of Support And Resistance For RCEL Stock
The 24-hour chart illustrates a support level at 7.67, which if violated will result in even more drops to 7.47. On the upside, there is a resistance level at 8.02. A further resistance level may holdings at 8.17. The Relative Strength Index (RSI) on the 14-day chart is 38.48, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.30, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 85.56%. Stochastics%K at 7.93% indicates the stock is a buying.
The most recent change occurred on April 21, 2020 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $9 price target.
